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sample	 t	 tests	were	 used	 to	 compute	 differences	 between	 the	 first	 and	 subsequent	
measurements.	T0–T1	and	T0–T2	comparisons	indicate	a	significant	reduction	in	mean	
decisional	conflict	scores	with	stronger	effects	for	participants	with	high	baseline	deci‐
sional	 conflict.	 Furthermore,	 use	 of	 the	 decision	 aid	 resulted	 in	 increased	 knowledge	
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1  | INTRODUC TION
Most	 hereditary	 cancer	 syndromes	 follow	 an	 autosomal‐dom‐
inant	 inheritance	 pattern,	 implying	 that	 there	 is	 a	 50%	 risk	 of	
transmitting	a	pathogenic	variant	to	offspring,	with	a	high	risk	of	
a	future	malignancy	as	a	consequence.	For	the	relatively	frequent	
breast	 cancer	 gene	mutations	 in	BRCA1 or BRCA2,	 this	 implies	
risks	of	27%–57%	and	6%–40%	of	developing	breast	respectively	
ovarian	 cancer	 by	 the	 age	 of	 70	 (Brohet	 et	 al.,	 2014;	 Chen	 &	
Parmigiani,	2007).	Persons	having	a	genetic	predisposition	to	can‐
cer	and	their	partners	have	to	make	fundamental	decisions	about	
future	 reproduction	 and	 face	 difficult	 challenges	 (Dekeuwer	 &	
Bateman,	2013;	Derks‐Smeets	et	al.,	2014;	Donnelly	et	al.,	2013;	
van	Asperen	 et	 al.,	 2002).	Couples	 have	 three	options	 to	 fulfill	
their	wish	for	a	child	that	 is	genetically	related	to	both	parents.	
The	 first	 option	 is	 natural	 conception	 without	 genetic	 testing,	
implying	acceptance	or	 taking	the	risk	of	passing	on	the	patho‐
genic	 variant.	 Furthermore,	 there	 are	 two	 options	 for	 having	 a	
genetically	 related	 child	 to	 both	 parents	 without	 a	 pathogenic	
variant.	 The	 first	 option	 is	 natural	 conception	with	prenatal	 di‐
agnosis	(PND),	offering	the	choice	to	terminate	the	pregnancy	if	
the	fetus	has	the	pathogenic	variant	(de	Die‐Smulders,	de	Wert,	
Liebaers,	 Tibben,	&	Evers‐Kiebooms,	 2013).	 The	 second	option	
is	 preimplantation	genetic	 diagnosis	 (PGD).	PGD	offers	 the	op‐
tion	 to	obtain	embryos	by	 in	vitro	 fertilization	 (IVF)	and	screen	
them	for	the	familial	pathogenic	variant.	Only	embryos	without	
the	 pathogenic	 variant	 are	 transferred	 into	 the	 uterus	 (de	Die‐
Smulders	 et	 al.,	 2013).	 Levels	 of	 awareness	 for	 PND	 (61%)	 and	
PGD	 (66%)	 are	 similar,	 and	 couples	 consider	 PGD	 (80%)	 to	 be	
more	acceptable	 for	hereditary	cancer	compared	 to	PND	 (26%)	
(Gietel‐Habets	et	al.,	2017).
Couples	 may	 experience	 difficulties	 with	 reproductive	 de‐
cision‐making	 (Dekeuwer	 &	 Bateman,	 2013;	 Dommering	 et	 al.,	
2010;	Ormondroyd	et	al.,	2012),	and	it	was	reported	that	for	some,	
even	years	later,	the	impact	of	reproductive	decision‐making	still	
had	an	 influence	on	 their	 lives	at	a	daily	basis	 (Derks‐Smeets	et	
al.,	2014).	 In	deliberating	the	options,	couples	consider	personal	
values	and	 (dis)advantages	of	 the	options,	 such	as	physical	 (e.g.,	
burden	of	PGD	treatment),	psychological	(e.g.,	loss	of	sense	of	ro‐
mance),	social	(e.g.,	elimination	of	the	pathogenic	variant	in	family	
line),	ethical	 (e.g.,	moral	duty	 to	protect	 the	child),	 and	practical	
considerations	(e.g.,	reimbursement	of	treatment)	(Derks‐Smeets	
et	al.,	2014).	Which	reproductive	option	suits	 them	best,	should	
ideally	 be	 decided	 in	 an	 informed	 decision‐making	 process	 by	
an	 educated	 and	 empowered	 couple,	 supported	 by	 a	 dedicated	
health	 care	 provider.	 In	 order	 to	 promote	 informed	 reproduc‐
tive	 decision‐making,	 the	 use	 of	 decision	 aids	 can	 be	 effective	




the	 International	 Patient	 Decision	 Aids	 Standards	 (Reumkens,	
Oudheusden,	 et	 al.,	 2018;	 Reumkens,	 Tummers,	 et	 al.,	 2018;	
Volk,	Llewellyn‐Thomas,	Stacey,	&	Elwyn,	2013).	In	this	study,	we	
report	 on	 the	 effects	 of	 the	 decision	 aid	 evaluated	 in	 a	 nation‐





Departments	 in	 the	 Netherlands	 recruited	 eligible	 couples	 during	
or	 after	 oncogenetic	 consultations	 from	 January	 2017	 to	 January	
2018.	Couples	were	 eligible	 for	 participation	 if	 one	partner	 had	 a	
pathogenic	variant	predisposing	for	autosomal	dominant	hereditary	
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Eligible	 couples	were	 provided	with	 an	 information	 brochure	 in‐







were	 monitored.	 Immediately	 after	 use	 of	 the	 decision	 aid,	 par‐
ticipants	 were	 directed	 to	 the	 second	 questionnaire	 (T1).	 Two	
weeks	 after	 baseline,	 participants	were	 asked	 by	 e‐mail	 to	 com‐
plete	 a	 third	 questionnaire	 (T2).	 A	 reminder	was	 sent	 to	 partici‐
pants	who	did	not	complete	the	T1	questionnaire	within	1	day,	or	














population	 diagrams)	 (Reumkens,	 Oudheusden,	 et	 al.,	 2018;	
Trevena	et	al.,	2013).








6.	 A	question	prompt	 sheet,	 providing	 examples	of	 questions	 and	
requests	for	additional	information	and	space	for	own	questions.
7.	 Information	 regarding	 the	 scientific	 resources	used	 to	underpin	





at	 T0.	 Less	 than	 primary	 education,	 primary	 and	 lower	 secondary	
education	were	considered	as	low	education	levels.	Upper	second‐
ary	 and	 post‐secondary	 non‐tertiary	 education	 were	 considered	
as	middle	education	levels.	Tertiary	education	was	considered	as	a	
high	education	level.	At	T0	and	T2,	couples	were	also	asked	if	they	





The	 primary	 outcome	 measure,	 that	 is,	 participants’	 level	 of	
decisional conflict (at	 T0,	 T1,	 T2),	 was	 assessed	 by	 the	 Decisional	




personal	 beliefs	 regarding	 the	 reproductive	 options,	 three	 items	
(α	=	0.63)	assessed	 feelings	of	being	supported	 in	making	a	 repro‐
ductive	 decision,	 and	 four	 items	 (α	=	0.82)	 assessed	 the	 feeling	 of	
having	made	 an	 effective	 decision.	 Each	 item	was	 scored	 on	 a	 5‐
point	Likert	scale	ranging	from	0	(strongly	agree)	to	4	(strongly	dis‐












ception,	 there	 is	a	50%	risk	of	 transmitting	the	pathogenic	variant	
to	offspring”;	1	=	correct,	2	=	incorrect,	3	=	not	sure),	five	questions	













one	 IVF	 treatment	with	PGD?”,	 “What	 is	 the	 risk	of	 complications	
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Evaluative items	 (T1).	 Participants	were	 asked	 to	 give	 an	 over‐
all	appreciation	score	for	the	decision	aid	at	a	scale	from	1–10	and	
to	indicate	in	open‐ended	questions	positive	and	negative	features	




















for	 clustering	within	 couples.	 Both	models	 yielded	 similar	 results,	
















completed	T2	 (64.7%).	 80.4%	of	 the	participants	 filled	out	 the	T1	
questionnaire	immediately	after	visiting	the	decision	aid.	T2	was	on	




SD =	3.6)	 was	 slightly	 higher	 compared	 to	 females	 (M	=	29.2,	
SD =	2.9).	 Most	 participants	 were	 highly	 educated	 (57.4%).	 The	
most	 frequently	 reported	hereditary	 cancer	 syndrome	was	HBOC	
(85.2%).The	majority	 of	 the	 participants	 (89%)	 already	 had	 a	 con‐
sultation	 in	 which	 the	 reproductive	 options	 were	 discussed.	 The	
consultation,	mostly	with	clinical	geneticists,	focused	mainly	on	the	
consequences	of	having	the	pathogenic	variant	(58.9%).	In	41.1%	of	




































Note.	 FAP:	 Familial	Adenomatous	Polyposis;	HBOC:	Hereditary	 breast	
and ovarian cancer.











































































































































































































































































































































































































































































































































































































































































































































































































3.2 | Effects of the decision aid
As	 shown	 in	 Table	 2,	 total	 mean	 decisional conflict	 scores	 (range	
0–100)	 for	all	 five	subscales	significantly	decreased	 from	25.30	at	
baseline,	 to	 18.06	 at	 T1	 (Effect	 Size	 (ES)	=	0.73)	 and	 17.22	 at	 T2	
(ES	=	0.51).	 Total	 mean	 decisional	 conflict	 scores	 (range	 0–100)	
excluding	 the	 effective	 decision	 subscale,	 significantly	 decreased	
from	35.54	at	baseline,	to	25.33	at	T1	(ES	=	0.78)	and	26.31	at	T2	
(ES	=	0.44).	 In‐depth	 analyses	 (Table	 3)	 indicated	 that	 participants	
with	high	baseline	decisional	conflict	scores	(≥33),	excluding	the	ef‐
fective	decision	subscale,	had	a	significant	reduction	in	total	scores	
from	 baseline	 (M	=	51.35)	 to	 T1	 (M	=	34.46;	 ES	=	1.29)	 and	 T2	
(M	=	34.72;	 ES	=	0.80)	whereas	 participants	with	 low	 baseline	 de‐
cisional	conflict	scores	(<33)	only	showed	a	significant	reduction	in	
total	scores	at	T1	(ES	=	0.43).
As	 shown	 in	 Table	 2,	 the	 mean	 level	 of	 knowledge	 (range	
0–15)	 significantly	 increased	 from	 9.28	 at	 baseline,	 to	 13.16	 at	
T1	 (ES	=	−1.37)	 and	 12.63	 at	 T2	 (ES	=	−1.11).	 In‐depth	 analyses	
(Table	3)	indicated	that	knowledge	scores	significantly	increased	
for	 both	 participants	 with	 high	 (>10)	 and	 low	 (≤10)	 baseline	
knowledge	levels.
As	 shown	 in	 Table	 2,	Realistic expectations	 (range	 0–3)	 signifi‐












As	 shown	 in	 Table	 2,	 participants’	 decision self‐efficacy	 (range	
0–100)	 did	 not	 significantly	 increase	 from	 baseline	 (77.23)	 to	 T1	
(79.43;	ES	=	−0.16).	From	baseline	to	T2,	decision	self‐efficacy	sig‐
nificantly	 increased	 (M	=	79.81;	 ES	=	−0.23).	 In‐depth	 analyses	





3.3 | Depth of use of the decision aid
As	shown	in	Table	4,	both	users	with	 low	engagement	(≤15	pages)	
and	users	with	high	engagement	(>15	pages)	showed	decreased	de‐
cisional	 conflict	 scores,	 increased	knowledge	 levels,	 and	 increased	
TA B L E  3   In‐depth	analyses	for	main	outcome	measures	based	on	median	split	baseline	scores
T0 (baseline)
T1 (immediately 
after use of the 
decision aid)
T2 (2 weeks 
after baseline) T0–T1 T0–T2
Means (SD) Means (SD) Means (SD) T p ES T p ES
Decisional	conflict	(0–100)a
Low	baseline	(<33) 21.23	(9.77) 17.06	(11.13) 18.79	(16.00) 3.16 0.003 0.43 0.82 0.419 0.12
High	baseline	(≥33) 51.35	(13.36) 34.46	(15.10) 34.72	(19.78) 8.92 <0.001 1.29 5.16 <0.001 0.80
Knowledge	(0–15)
Low	baseline	(≤10) 6.93	(2.12) 12.70	(2.04) 12.11	(1.94) −14.04 <0.001 −2.07 −11.11 <0.001 −1.83
High	baseline	(>10) 11.21	(1.36) 13.54	(1.61) 13.02	(1.80) −10.38 <0.001 −1.39 −6.57 <0.001 −0.94
Realistic	expectations	(0–3)
Low	baseline	(≤1) 0.54	(0.50) 1.52	(1.11) 0.98	(0.89) −9.32 <0.001 −0.92 −4.85 <0.001 −0.48
High	baseline	(≥2) 2.15	(0.38) 2.46	(0.88) 1.85	(1.14) −1.17 0.264 −0.32 0.94 0.367 0.26
Level	of	deliberation	(6–30)
Low	baseline	(≤24) 19.44	(4.06) 22.19	(3.36) 22.27	(3.46) −3.22 0.003 −0.57 −2.68 0.013 −0.53
High	baseline	(>24) 27.22	(2.03) 26.48	(2.99) 26.39	(3.14) 1.43 0.166 0.27 1.30 0.208 0.27
Decision	self‐efficacy	(0–100)
Low	baseline	(≤75) 67.00	(7.42) 73.07	(15.16) 75.78	(13.59) −3.20 0.003 −0.47 −6.59 <0.001 −1.03
High	baseline	(>75) 88.18	(6.98) 86.11	(13.95) 82.45	(14.60) 0.92 0.361 0.14 2.22 0.033 0.37
aDecisional	conflict	scale	excluding	effective	decision	subscale.	
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realistic	expectations	at	T1	and	T2	(all	p's	<	0.05;	decisional	conflict	
in	high	engagement	group:	p	=	0.05).	Only	users	with	high	engage‐
ment	 showed	 increased	 levels	 of	 deliberation	 and	 increased	 deci‐
sional	self‐efficacy	at	T1	and	T2	(all	p's	<	0.05).
3.4 | Evaluation of the acceptability
The	mean	score	on	the	Preparation	for	Decision	Making	Scale	(range	
0–100)	 was	 62.3	 (SD =	19.6).	 A	 majority	 (82.2%)	 thought	 it	 was	
easy	 to	 find	 information	 in	 the	decision	aid	 (M	=	3.24,	SD =	0.81),	
found	 the	 various	 functions	 well	 integrated	 (84.2%,	 M	=	3.05,	
SD =	0.73),	 the	 information	 offered	 consistent	 (90.1%,	 M	=	3.43,	
SD =	0.70),	and	relevant	(82.6%,	M	=	3.41,	SD =	0.64).	Furthermore,	
participants	 found	 the	decision	aid	easy	 to	use	 (90.1%,	M	=	3.22,	
SD =	0.74)	 and	 trusted	 the	 offered	 information	 (94.1%,	M	=	3.40,	






Participants	 graded	 the	decision	 aid	 on	 a	 scale	 of	 1–10	with	 a	
mean	of	8.2	(SD =	0.94).	The	avoidance	of	medical	or	technical	terms	
was	 appreciated	 and	 the	 provided	 information	 was	 clear,	 neutral	
(i.e.,	not	guiding)	and	comprehensible.	Particularly,	the	value	clarifi‐
cation	exercises	and	informational	videos	were	appreciated,	but	the	







ductive	options.	Overall	 immediate	 (T0–T1)	and	 sustained	 (T0–T2)	
effects	 were	 found	 for	 decisional	 conflict,	 knowledge,	 and	 realis‐
tic	 expectations,	 only	 sustained	 effects	were	 found	 for	 decisional	
self‐efficacy.	No	main	 effects	were	 demonstrated	 for	 the	 level	 of	
deliberation.	However,	analyses	on	depth	of	use	of	the	decision	aid	
showed	 that	users	with	high	engagement	 showed	a	 significant	ef‐
fect	on	all	outcome	measures.	This	indicates	that	using	the	decision	
aid	 to	 its	 full	 extent	 positively	 influences	 all	main	 outcome	meas‐
ures.	Furthermore,	 in‐depth	analyses	 showed	both	 immediate	and	
sustained	effects	in	increasing	deliberation	among	those	with	lower	
baseline	 levels	of	deliberation.	This	 indicates	 that	 the	decision	aid	
is	 capable	 of	 encouraging	 deliberation	 among	 couples	who	 are	 in	
the	 early	 stages	 of	 decision‐making	 (Elwyn	&	Miron‐Shatz,	 2010).	
Furthermore,	in‐depth	analyses	showed	stronger	effects	for	partici‐









uisite	 for	 informed	 decision‐making	 (Van	 den	 Berg	 et	 al.,	 2006).	
TA B L E  4  Effects	of	the	decision	aid	related	to	depth	of	use
T0 (baseline)
T1 (immediately after use 
of the decision aid)
T2 (2 weeks 
after baseline) T0–T1 T0–T2
Means (SD) Means (SD) Means (SD) T p ES T p ES
Decisional	conflict	(0–100)a
Low	engagementb 35.75	(21.12) 27.08	(15.83) 25.57	(16.99) 4.48 <0.001 0.63 3.93 <0.001 0.59
High	engagementc 35.55	(16.95) 23.58	(15.85) 27.79	(22.35) 6.58 <0.001 0.96 2.02 0.050 0.32
Knowledge	(0–15)
Low	engagement 9.22	(2.97) 12.37	(2.03) 11.95	(1.93) −7.59 <0.001 −1.06 −5.64 <0.001 −0.85
High	engagement 9.34	(2.64) 14.00	(1.14) 13.39	(1.62) −12.94 <0.001 −1.89 −8.96 <0.001 −1.45
Realistic	expectations	(0–3)
Low	engagement 0.64	(0.76) 1.45	(1.14) 1.08	(1.03) −5.49 <0.001 −0.75 −3.25 0.002 −0.45
High	engagement 0.84	(0.65) 2.08	(0.90) 1.24	(0.87) −9.81 <0.001 −1.39 −2.92 0.005 −0.41
Level	of	deliberation	(6–30)
Low	engagement 23.63	(4.72) 22.87	(4.33) 23.51	(3.99) 1.13 0.268 0.18 0.20 0.842 0.03
High	engagement 22.58	(4.23) 24.78	(2.64) 24.67	(2.72) −3.43 0.002 −0.57 −2.31 0.028 −0.42
Decision	self‐efficacy	(0–100)
Low	engagement 77.68	(13.42) 77.64	(16.85) 77.38	(15.19) 0.02 0.985 0.00 0.04 0.968 0.01
High	engagement 76.89	(11.44) 81.19	(14.21) 82.00	(12.96) −2.67 0.010 −0.39 −3.65 0.001 −0.60
aDecisional	conflict	scale	excluding	effective	decision	subscale.	b≤15	pages.	c>15	pages.	
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Post‐hoc	 analyses	 indicated	 that	 baseline	 knowledge	 levels	 were	
identical	for	participants	with	low	and	high	baseline	scores	of	deci‐
































high	 compared	 to	 the	 numbers	 in	 the	 general	 Dutch	 population	
(30%)	 (CBS,	2016).	 This	 further	 exposes	 the	need	 for	 research	on	
measures	 to	 improve	 referral	of	patients	with	a	 lower	educational	
background.	Furthermore,	as	the	reproductive	decision	is	often	not	





Use	of	 the	decision	aid	 resulted	 in	several	positive	outcomes	 in‐
dicative	of	informed	decision‐making	which	may	lessen	the	nega‐
















tive	options.	 Further	 research	 is	 needed	 to	 indicate	prolonged	ef‐
fects	on	informed	decision‐making	and	informed	choice.
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